Corvus Pharmaceuticals, Inc. — SC 13D/A Filings
12 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Corvus Pharmaceuticals, Inc. (CRVS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Corvus Pharmaceuticals, Inc. has filed 12 SC 13D/A documents with the SEC since 2014. To view all SEC filings by Corvus Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B4
424B5
5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | AMENDMENT NO. 9 | 0000947871-24-000449 | May 8, 2024 | — |
| SC 13D/A | AMENDMENT NO. 8 | 0000947871-21-001134 | Nov 3, 2021 | — |
| SC 13D/A | AMENDMENT NO. 7 | 0000947871-21-001015 | Sep 22, 2021 | — |
| SC 13D/A | AMENDMENT NO. 6 | 0000947871-21-000874 | Aug 4, 2021 | — |
| SC 13D/A | AMENDMENT NO. 5 | 0000947871-21-000229 | Feb 17, 2021 | — |
| SC 13D/A | AMENDMENT NO. 3 TO SCHEDULE 13D | 0001193125-20-190472 | Jul 9, 2020 | — |
| SC 13D/A | AMENDMENT NO. 4 | 0000947871-20-000390 | Apr 17, 2020 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-205471 | Jul 29, 2019 | — |
| SC 13D/A | AMENDMENT NO. 3 | 0000947871-19-000489 | Jul 2, 2019 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-023789 | Jan 31, 2019 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000947871-18-000247 | Mar 14, 2018 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-18-000063 | Jan 26, 2018 | — |